Cargando…
EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclides
BACKGROUND: There is limited effect of tyrosine kinase inhibitors or “naked” antibodies binding EGFR or HER2 for therapy of metastasized urinary bladder cancer and these methods are therefore not routinely used. Targeting radio-nuclides to the extracellular domain of the receptors is potentially a b...
Autores principales: | Carlsson, Jörgen, Wester, Kenneth, De La Torre, Manuel, Malmström, Per-Uno, Gårdmark, Truls |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Versita, Warsaw
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362606/ https://www.ncbi.nlm.nih.gov/pubmed/25810701 http://dx.doi.org/10.2478/raon-2014-0015 |
Ejemplares similares
-
Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe)
por: Häggström, Christel, et al.
Publicado: (2017) -
HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review
por: Carlsson, J, et al.
Publicado: (2004) -
EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: Implications for targeted radiotherapy
por: Shen, Li, et al.
Publicado: (2008) -
Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0
por: Häggström, Christel, et al.
Publicado: (2022) -
Comparison of HER2 expression between primary colorectal cancer and their corresponding metastases
por: Lee, Won-Suk, et al.
Publicado: (2014)